- Home
- Research
- Endocannabinoid
- N-Arachidonoyl-phosphatidylethanolamide phospholipase D activation by muscarinic receptors.
How nerve signals may trigger the body’s own anandamide
N-Arachidonoyl-phosphatidylethanolamide phospholipase D activation by muscarinic receptors.
AI Summary
This study examined how the body produces anandamide, one of its two major endocannabinoid messengers. In human kidney-derived cells, activating muscarinic M3 receptors—a type of receptor stimulated by the neurotransmitter acetylcholine—triggered an endocannabinoid signal only when the cells contained the enzyme NAPE-PLD. The response was reduced by a NAPE-PLD inhibitor and depended on phospholipase C and calcium released from internal stores.
The researchers also found the same pattern in lacrimal and salivary glands, where M3 receptors and NAPE-PLD were present in the same cells. Sensor experiments indicated that the glands produced anandamide, rather than 2-AG, after muscarinic stimulation. The findings suggest that acetylcholine-driven nerve activity may engage anandamide as a local feedback signal, potentially helping regulate gland function and neurotransmitter release. This was a cell and tissue study—not a clinical trial—so it does not show that cannabis, THC, or CBD produces the same effects in people, and the abstract reports no clinical outcomes or quantitative effect sizes.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Endocannabinoid research papers you might find interesting.
Review links cannabis to possible heart attack mechanisms, not proven risk
Visceral fat endocannabinoid production rose with diabetes, not obesity alone
Targeted CB2 drug delivery reduced mouse plaque deposits, with sex differences
Explore More Research
Stay informed about the latest cannabis science.